• Skip to navigation (Access key ‘n’)
  • Skip to page content (Access key ‘c’)
National Horizon Scanning Centre logoNational Horizon Scanning Centre
University of Birmingham NHS National Institute for Health Research
  • Home
  • About Us
    • Methods
    • Customers & Partners
    • Glossary
    • Governance
    • Related Links
    • Who's Who?
  • Outputs
    • Outputs by Specialty
    • Research & Publications
    • Other Reports
  • News
  • Suggest a topic
  • Contact Us

More Search Options

Filtering options e.g. by technology type, and for multiple years are available within the results

Eye Disease

Filter topics in this Specialty Topics can be filtered and/or combined by year of entry, technology type, and other specialties

  • Drug Briefings (14)
  • Diagnostic Briefings (0)
  • Device Briefings (6)
  • Other Reports (0)

Ocriplasmin (Microplasmin) for symptomatic vitreomacular adhesion (sVMA) – first line

Date:1 September 2011

Aganirsen for pathological corneal neovascularisation

Date:1 August 2011

Idebenone (Catena) for Leber's hereditary optic neuropathy – first line

Date:1 August 2011

Ranibizumab (Lucentis) for visual impairment due to choroidal neovascularisation (CNV) secondary to pathological myopia - first line

Date:1 August 2011

VEGF Trap-Eye (Eylea) for macular oedema secondary to central retinal vein occlusion – first line

Date:1 May 2011

Dexamethasone intravitreal implant (Ozurdex) for non-infectious posterior uveitis

Date:1 December 2010

VEGF Trap-Eye for neovascular (wet) age-related macular degeneration (AMD)

Date:1 December 2010

AIN-457 for chronic non-infectious posterior uveitis - second line

Date:1 August 2010

Pegaptanib sodium (Macugen) for diabetic macular oedema - first line

Date:1 April 2010

Fluocinolone acetonide intravitreal insert (Iluvien) for diabetic macular oedema

Date:1 December 2009

Dexamethasone intravitreal implant (Posurdex) for macular oedema - due to retinal vein occlusion

Date:1 August 2009

Ranibizumab (Lucentis) for macular oedema - retinal vein occlusion (CRVO and BRVO)

Date:1 April 2009

Ranibizumab (Lucentis) for diabetic macular oedema

Date:1 April 2009

Voclosporin (ISA-247) for non-infectious uveitis - active and quiescent

Date:1 August 2008

EyeOP1® for glaucoma

Date:1 January 2012

IRay™ for wet age related macular degeneration

Date:1 December 2011

Argus II™ Retinal Prosthesis System for peripheral retinal degeneration

Date:1 June 2011

AcrySof® – a new intraocular lens for patients with cataracts and corneal astigmatism

Date:1 June 2010

VIDION® Strontium-90 (β-radiation brachytherapy system) for neovascular age-related macular degeneration

Date:1 February 2010

Implantable miniature telescopes for age-related macular degeneration

Date:1 January 2006

NIHR Horizon Scanning Centre, School of Health & Population Sciences, University of Birmingham,
90 Vincent Drive, Edgbaston, Birmingham B15 2SQ
Tel: +44 (0)121 414 7831 Email: nhscadmin@contacts.bham.ac.uk

© University of Birmingham 2000-2012

Made Media Ltd.